Latest Product Pipeline News

Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.

Pacific Edge reported a $35.8 million loss in FY26 amid a 47% revenue drop following Medicare coverage loss, but a draft Medicare policy and $36.1 million capital raise set the stage for recovery.

New Murchison Gold Limited (ASX:NMG) has boosted its Garden Gully Gold Project mineral resource by 47%, adding maiden resources for Lydia and Abbotts and lifting total contained gold to 359,000 ounces.

Baby Bunting anticipates FY26 pro forma NPAT between $16 million and $17 million, marking a 32% to 40% increase from FY25, despite weaker sales in the fourth quarter. The retailer’s Store of the Future refurbishments and online channels continue to drive growth amid a challenging consumer backdrop.

Austral Gold has confirmed significant silver-gold mineralisation across multiple veins at its Juncal Project in Chile, setting the stage for its first-ever drilling campaign.

Peak Processing has reported three consecutive months of positive EBITDA and raised its Q4 FY26 beverage production guidance to approximately 1.6 million units, surpassing earlier estimates.

Bass Oil has landed a $3.5 million grant from the South Australian Government to fund a production pipeline for its 100% owned Kiwi gas project, aiming to connect it to Cooper Basin infrastructure and boost domestic gas supply by 2028.

Knosys has locked in a two-year, $3.8 million contract extension with ANZ, with full payment received upfront. This deal underpins Knosys’s role in ANZ’s AI integration efforts and strengthens the company’s cash position.

Barton Gold reports standout high-grade assays from Phase 2 drilling at Tunkillia’s Area 51, highlighting potential resource growth and open pit extensions that could extend mine life and underpin a Pre-Feasibility Study by year-end.

XReality Group (ASX:XRG) posts strong FY26 revenue and ARR growth, marking key milestones with its first commercial MR-1 mixed reality sale to the US Department of Defense and debut European contract with the Swedish Armed Forces.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Pacific Edge reported a steep 47% revenue drop in FY26 following Medicare coverage loss but secured a draft Medicare policy covering its Cxbladder tests and raised NZ$25.4 million to fuel growth and commercial execution.